Login / Signup

The effects of immune checkpoint modulators on the clinical course of patients with resectable hepatocellular carcinoma.

Jihyun AnHyo Jeong KangEunsil YuHan Chu LeeJu Hyun Shim
Published in: Journal of liver cancer (2022)
Immune checkpoint proteins upregulated in TIMCs in HCC tissues have individual and additive effects in prolonging the survival of patients, specifically in terms of survival not related to cancer recurrence.
Keyphrases
  • end stage renal disease
  • free survival
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • small molecule
  • gene expression
  • prognostic factors
  • papillary thyroid
  • patient reported outcomes
  • patient reported